BLTE compared with IRTC: revenue, margins and what each company keeps, and the suppliers and customers both name

BLTEBelite Bio, Inc

Mkt capRevenueRevenue

IRTCiRhythm Holdings, Inc.

Mkt capRevenueRevenue

Compare

BLTEBelite Bio, Inc

IRTCiRhythm Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

BLTE: latest quarter not drawable. IRTC: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

BLTE, solidIRTC, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BLTE 1

—The Trustees of Columbia University in the City of New Yorkunlistedsupplier

Shared 0

No shared counterparties.

Only IRTC 16

—the Medicare program through CMSunlistedcustomer

—BioISunlistedsupplier

—Sutherland Healthcare Solutionsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Techindia Infoway Privateunlistedsupplier

12 more · IRTC chain ›

BLTEBelite Bio, Inc

153.60▼−0.74%· post 153.59

Mkt cap$6.0BRevenue—Revenue—

IRTCiRhythm Holdings, Inc.

123.54▲+0.14%· post 126.17

ClosedNov 2 '26

Mkt cap$4.1BRevenue$224MQ2 FY26Revenue$747MFY25

Compare

ClosedNov 2 '26

BLTEBelite Bio, Inc

IRTCiRhythm Holdings, Inc.

153.60▼−0.74%post 153.59

Price

123.54▲+0.14%post 126.17

$6.0B

Mkt cap

$4.1B

—

Revenue

$224MQ2 FY26

—

Revenue

$747MFY25

BLTE153.60▼−0.74%vsIRTC123.54▲+0.14%ClosedNov 2 '26